Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSG for Salivary Gland Protection in PSMA PET Imaging
NCT04282824Phase 1Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jun 2019
- Primary completion
- May 2020
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in prostate carcinoma (2 arms), sponsored by UCLA Jonsson Comprehensive Cancer Center. Primary endpoint: Salivary gland uptake of gallium Ga 68-labeled PSMA-11. Started Jun 2019; status: completed.
02
Conditions
prostate carcinoma
Beyond the preview
Go deeper on NCT04282824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04282824.